Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize!
Attractive stocks have exceptional fundamentals. In the case of Deceuninck NV (EBR:DECB), there’s is a highly-regarded dividend-paying company that has been able to sustain great financial health over the past. In the following section, I expand a bit more on these key aspects. For those interested in digger a bit deeper into my commentary, read the full report on Deceuninck here.
Adequate balance sheet average dividend payer
DECB’s ability to maintain an adequate level of cash to meet upcoming liabilities is a good sign for its financial health. This suggests prudent control over cash and cost by management, which is an important determinant of the company’s health. DECB appears to have made good use of debt, producing operating cash levels of 0.25x total debt in the prior year. This is a strong indication that debt is reasonably met with cash generated.
Income investors would also be happy to know that DECB is a great dividend company, with a current yield standing at 1.4%. DECB has also been regularly increasing its dividend payments to shareholders over the past decade.
Next Steps:
For Deceuninck, I’ve put together three key factors you should further research:
- Future Outlook: What are well-informed industry analysts predicting for DECB’s future growth? Take a look at our free research report of analyst consensus for DECB’s outlook.
- Historical Performance: What has DECB’s returns been like over the past? Go into more detail in the past track record analysis and take a look at the free visual representations of our analysis for more clarity.
- Other Attractive Alternatives : Are there other well-rounded stocks you could be holding instead of DECB? Explore our interactive list of stocks with large potential to get an idea of what else is out there you may be missing!
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.